Navigate this Section
EBAA’s Affiliate Membership is designed for companies who are aligned in EBAA’s mission to restore sight. EBAA membership will help you find partners and customers, connect with eye banks and surgeons, and integrate into the broader vision-restoration community.
Gene & Cell Therapy
Industry Partners
Gene and cell therapy companies join at a tiered rate based on clinical stage — from $2,500 for pre-clinical companies through $10,000 for those with an approved product on market. In addition to core member benefits, this category includes regulatory briefings, webinars, and advocacy support specific to biologics and cell and gene therapies.
All tiers include access to 80+ eye banks and the clinical community, EyeConnect networking, EyeLearn, EBAA publications and data, meeting discounts, website listing, and logo use rights.
Member Benefits
Networking Opportunities
- Exclusive access to 80+ eye banks in the US and worldwide, plus hundreds of corneal clinicians and researchers
- Opportunities to serve on select EBAA committees
- Access to EyeConnect, EBAA’s online networking platform exclusive to members
- Virtual roundtables and other connection opportunities in small group settings
- Member engagement and networking receptions at the EBAA Annual & Fall Meetings
- Support with clinical trial development and recruitment through member eye banks
Visibility and Recognition
- Opportunities to present scientific research at the Cornea & Eye Banking Forum and other venues
- Recognition on EBAA’s website — company name, logo, website, and description
- Use of EBAA logo on your website and in corporate communications
Member Savings
- 33% discount on exhibiting at the Annual Meeting
- 33% discount on exhibiting at the Cornea & Eye Banking Forum
- Complimentary access to EBAA webinars and all EyeLearn resources
- 25% discount on EBAA sponsorship opportunities
- Discount on all EBAA meeting registrations
Data and Insights
- Access to EBAA’s extensive data and insights on eye banking statistical reporting
- Complimentary access to EBAA publications and reports
- Member communications ~3x/week on regulatory, legislative, and association issues
Regulatory Benefits — Exclusive to Gene & Cell Therapy Members
- Curated regulatory updates specific to corneal technologies
- Webinars on regulatory requirements and advocacy initiatives
- Reports and email updates on regulatory developments
- Exclusive briefings on issues specific to biologics and gene and cell therapies
| Tier & Fee | Stage | What matters most at this stage |
|---|---|---|
|
Pre-Clinical $2,500 per year |
Research stage No IND filed; lab or animal studies only. Typically seed or Series A funded. |
Clinician and eye banker feedback Access to surgeons and eye bankers who can validate whether your approach addresses a real clinical need — and who may become scientific advisors or co-investigators. EBAA transplant data Statistical data on transplant volumes, tissue utilization, and disease prevalence — useful for refining research direction and strengthening investor materials. Credibility and affiliation EBAA membership signals legitimacy to investors evaluating the ocular space. Website listing and logo use rights make that affiliation visible. |
|
Early / Mid-Clinical $5,000 per year |
Phase 1 / 2 Active IND on file; Phase 1, 1/2, or 2 trials underway. Includes RMAT-designated companies. Typically Series A or B funded. |
Eye bank connections for trial support and tissue access Introductions to eye banks that can supply human donor tissue for ex vivo research, identify trial sites, refer patients, and support tissue logistics. Gene/cell therapy-specific regulatory briefings Exclusive briefings on biologics requirements and IND-stage regulatory issues, beyond general updates available to all members. Research presentation opportunities Platform to present early data at the Cornea & Eye Banking Forum — building credibility with the clinical community that will ultimately adopt your therapy. |
|
Late Clinical $7,500 per year |
Phase 3 / BLA Phase 3 trials underway or BLA/NDA submitted. Typically Series C or later, or publicly traded. |
Multi-site eye bank partnerships for Phase 3 scale Facilitated connections across EBAA’s network of 50+ eye banks for large-scale patient recruitment. Advocacy and reimbursement support EBAA’s advocacy work and relationships with CMS can help build reimbursement groundwork ahead of launch. Pre-launch visibility Sponsorship opportunities and committee participation to build brand recognition before your product hits market. |
|
Commercial $10,000 per year |
FDA approved At least one product approved by FDA or equivalent and actively on the market. |
Eye bank distribution network Many EBAA member eye banks already distribute approved cell and gene therapy products. EBAA membership is a direct pathway to those relationships. Maximum visibility and sponsorship access Full sponsorship and exhibiting opportunities at the Annual Meeting and Forum. Committee leadership Opportunity to shape EBAA’s direction and standards in areas relevant to your product category. |
Not sure which tier applies to your company? We’re happy to talk through it.
For device, surgical tool, tissue processing, and other industry companies working within or adjacent to the eye banking and corneal transplant space.
Member Benefits
Networking Opportunities
- Exclusive access to 80+ eye banks in the US and worldwide, plus hundreds of corneal clinicians and researchers
- Opportunities to serve on select EBAA committees
- Access to EyeConnect, EBAA’s online networking platform exclusive to members
- Virtual roundtables and other connection opportunities in small group settings
- Member engagement and networking receptions at the EBAA Annual & Fall Meetings
- Support with clinical trial development and recruitment through member eye banks
- One dedicated EBAA email blast to 2,500+ members promoting your company
- Ability to record a 15-minute product presentation, promoted to EBAA members
Visibility and Recognition
- Opportunities to present scientific research at the Cornea & Eye Banking Forum and other venues
- Recognition on EBAA’s website — company name, logo, website, and description
- Use of EBAA logo on your website and in corporate communications
- Dedicated “Partner Spotlight” feature in an EBAA newsletter or on EyeConnect
- Welcome post on EBAA’s social channels when you join
Member Savings
- 33% discount on exhibiting at the Annual Meeting
- 33% discount on exhibiting at the Cornea & Eye Banking Forum
- Complimentary access to EBAA webinars and all EyeLearn resources
- 25% discount on EBAA sponsorship opportunities
- Discount on all EBAA meeting registrations
Data and Insights
- Access to EBAA’s extensive data and insights on eye banking statistical reporting
- Complimentary access to EBAA publications and reports
- Member communications ~3x/week on regulatory, legislative, and association issues
Tab 3
Lorem ipsum dolor sit amet. The graphic and typographic operators know this well, in reality all the professions dealing with the universe have a stable relationship with these words, but what is it? Lorem ipsum is a dummy text without any sense.
If you are going to use a passage of Lorem Ipsum, you need to be sure there isn’t hidden in the middle of text. All the Lorem Ipsum generators on the Internet tend to repeat predefined chunks as necessary, making the first true on the Internet.
Become a Member
As an early member of this program, you’ll have a direct line to shaping what we build next. We’re open to accommodating member needs where we can — if there’s something that would be particularly valuable to your company, we’d love to hear it.
